Page last updated: 2024-10-24

celecoxib and Headache Disorders

celecoxib has been researched along with Headache Disorders in 2 studies

Headache Disorders: Various conditions with the symptom of HEADACHE. Headache disorders are classified into major groups, such as PRIMARY HEADACHE DISORDERS (based on characteristics of their headache symptoms) and SECONDARY HEADACHE DISORDERS (based on their etiologies). (International Classification of Headache Disorders, 2nd ed. Cephalalgia 2004: suppl 1)

Research Excerpts

ExcerptRelevanceReference
"Indomethacin-responsive headaches encompass a group of disorders which include a subset of the trigeminal autonomic cephalalgias and other paroxysmal, often precipitated primary headaches."8.12Etoricoxib and celecoxib sensitive indomethacin-responsive headache disorders. ( Bahra, A; Farag, M, 2022)
"Indomethacin-responsive headaches encompass a group of disorders which include a subset of the trigeminal autonomic cephalalgias and other paroxysmal, often precipitated primary headaches."4.12Etoricoxib and celecoxib sensitive indomethacin-responsive headache disorders. ( Bahra, A; Farag, M, 2022)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's1 (50.00)2.80

Authors

AuthorsStudies
Farag, M1
Bahra, A1
Rossi, P1
Tassorelli, C1
Allena, M1
Ferrante, E1
Lisotto, C1
Nappi, G1

Reviews

1 review available for celecoxib and Headache Disorders

ArticleYear
Focus on therapy: hemicrania continua and new daily persistent headache.
    The journal of headache and pain, 2010, Volume: 11, Issue:3

    Topics: Amines; Analgesics; Celecoxib; Clinical Trials as Topic; Cyclohexanecarboxylic Acids; Fructose; Gaba

2010

Other Studies

1 other study available for celecoxib and Headache Disorders

ArticleYear
Etoricoxib and celecoxib sensitive indomethacin-responsive headache disorders.
    Headache, 2022, Volume: 62, Issue:3

    Topics: Anti-Inflammatory Agents, Non-Steroidal; Celecoxib; Etoricoxib; Headache; Headache Disorders; Humans

2022